Research ArticleSystemic Sclerosis
Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment
D. James Haddon, Hannah E. Wand, Justin A. Jarrell, Robert F. Spiera, Paul J. Utz, Jessica K. Gordon and Lorinda S. Chung
The Journal of Rheumatology May 2017, 44 (5) 631-638; DOI: https://doi.org/10.3899/jrheum.160833
D. James Haddon
From the Division of Immunology and Rheumatology, Stanford University School of Medicine; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford; Department of Rheumatology, Palo Alto VA Health Care System, Palo Alto, California; Department of Rheumatology, Hospital for Special Surgery, New York, New York,
USA.
Hannah E. Wand
Justin A. Jarrell
Robert F. Spiera
Paul J. Utz
Jessica K. Gordon
Lorinda S. Chung
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Spiera RF,
- Gordon JK,
- Mersten JN,
- Magro CM,
- Mehta M,
- Wildman HF,
- et al.
- 5.↵
- Pope J,
- McBain D,
- Petrlich L,
- Watson S,
- Vanderhoek L,
- de Leon F,
- et al.
- 6.↵
- 7.↵
- 8.↵
- Distler O,
- Distler JH,
- Varga J,
- Denton CP,
- Lafyatis RA,
- Wigley FM,
- et al.
- 9.↵
- Fraticelli P,
- Gabrielli B,
- Pomponio G,
- Valentini G,
- Bosello S,
- Riboldi P,
- et al;
- Imatinib in Scleroderma Italian Study Group
- 10.↵
- Chung L,
- Ruiz P,
- Wood T,
- Shoor S,
- Robinson W,
- Whitfield M,
- et al.
- 11.↵
- 12.↵
- Beirne P,
- Pantelidis P,
- Charles P,
- Wells AU,
- Abraham DJ,
- Denton CP,
- et al.
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- Khanna D,
- Furst DE,
- Hays RD,
- Park GS,
- Wong WK,
- Seibold JR,
- et al.
- 17.↵
- Gordon JK,
- Martyanov V,
- Magro C,
- Wildman HF,
- Wood TA,
- Huang WT,
- et al.
- 18.↵
- US National Institutes of Health
- 19.↵
- R Core Team
- 20.↵
- Tibshirani R,
- Chu G,
- Narasimhan B,
- samr Li J
- 21.↵
- Kolde R
- 22.↵
- 23.↵
- Hastie T,
- Tibshirani R,
- Narasimhan B,
- Chu G
- 24.↵
- Tibshirani R
- 25.↵
- Sing T,
- Sander O,
- Beerenwinkel N,
- Lengauer T
- 26.↵
- Tusher VG,
- Tibshirani R,
- Chu G
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- O’Reilly S,
- Hügle T,
- van Laar JM
- 35.↵
- 36.↵
- Allanore Y,
- Borderie D,
- Meune C,
- Lemaréchal H,
- Weber S,
- Ekindjian OG,
- et al.
- 37.↵
- Komura K,
- Sato S,
- Hasegawa M,
- Fujimoto M,
- Takehara K
- 38.↵
- 39.↵
- Pope J,
- Walker KM,
- de Leon F,
- Vanderhoek L,
- Seney S,
- Summers KL
- 40.↵
- 41.↵
- 42.↵
In this issue
The Journal of Rheumatology
Vol. 44, Issue 5
1 May 2017
Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment
D. James Haddon, Hannah E. Wand, Justin A. Jarrell, Robert F. Spiera, Paul J. Utz, Jessica K. Gordon, Lorinda S. Chung
The Journal of Rheumatology May 2017, 44 (5) 631-638; DOI: 10.3899/jrheum.160833
Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment
D. James Haddon, Hannah E. Wand, Justin A. Jarrell, Robert F. Spiera, Paul J. Utz, Jessica K. Gordon, Lorinda S. Chung
The Journal of Rheumatology May 2017, 44 (5) 631-638; DOI: 10.3899/jrheum.160833